Egalet

Collegium

This pharmaceutical company develops and commercialises prescription medicines for chronic pain and attention deficit hyperactivity disorder to help patients with serious medical conditions.

Orexo AB

This pharmaceutical company develops improved medications and digital therapies for patients with opioid use disorder, cancer pain and insomnia.

Latigo

This clinical-stage biopharmaceutical company develops non-opioid medicines to treat acute and chronic pain for patients needing alternatives to addictive painkillers.

PainReform

This pharmaceutical company develops extended-release anesthetic formulations to provide post-operative pain relief for surgical patients and reduce opioid dependency.

Depomed

This pharmaceutical company develops and markets branded prescription medicines for patients with neurology, oncology, and inflammatory conditions.

Opiant

This company develops pharmacological treatments for substance use, addictive and eating disorders for patients and healthcare providers.

Mimetic Medicines

This company develops non-opioid peptide drug candidates for patients suffering from chronic pain.

Latigo Biotherapeutics

This clinical-stage biopharmaceutical company develops non-opioid medicines to treat patients suffering from pain without the risk of addiction.